| Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: A children's oncology group study KR Schultz, WP Bowman, A Aledo, WB Slayton, H Sather, M Devidas, ... Journal of Clinical Oncology 27 (31), 5175-5181, 2009 | 845 | 2009 |
| Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study L Granowetter, R Womer, M Devidas, M Krailo, C Wang, M Bernstein, ... Journal of Clinical Oncology 27 (15), 2536-2541, 2009 | 383 | 2009 |
| Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions L Maldonado, JE Teague, MP Morrow, I Jotova, TC Wu, C Wang, ... Science translational medicine 6 (221), 221ra13-221ra13, 2014 | 221 | 2014 |
| Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404) BL Asselin, M Devidas, C Wang, J Pullen, MJ Borowitz, R Hutchison, ... Blood, The Journal of the American Society of Hematology 118 (4), 874-883, 2011 | 198 | 2011 |
| Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer MJ Fackler, Z Lopez Bujanda, C Umbricht, WW Teo, S Cho, Z Zhang, ... Cancer research 74 (8), 2160-2170, 2014 | 197 | 2014 |
| A pilot study of pNGVL4a-CRT/E7 (detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3) RD Alvarez, WK Huh, S Bae, LS Lamb Jr, MG Conner, J Boyer, C Wang, ... Gynecologic oncology 140 (2), 245-252, 2016 | 116 | 2016 |
| The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma A Begum, T Ewachiw, C Jung, A Huang, KJ Norberg, L Marchionni, ... PloS one 12 (7), e0180181, 2017 | 96 | 2017 |
| Statistical methods to compare functional outcomes in randomized controlled trials with high mortality E Colantuoni, DO Scharfstein, C Wang, MD Hashem, A Leroux, ... bmj 360, 2018 | 92 | 2018 |
| Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies C Wang, H Li, WC Chen, N Lu, R Tiwari, Y Xu, LQ Yue Journal of biopharmaceutical statistics 29 (5), 731-748, 2019 | 88 | 2019 |
| Bayesian analysis of heterogeneous treatment effects for patient-centered outcomes research NC Henderson, TA Louis, C Wang, R Varadhan Health Services and Outcomes Research Methodology 16, 213-233, 2016 | 63 | 2016 |
| Prospective EHR-based clinical trials: the challenge of missing data H Kharrazi, C Wang, D Scharfstein Journal of general internal medicine 29, 976-978, 2014 | 61 | 2014 |
| Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors CY Wu, LH Yang, HY Yang, J Knoff, S Peng, YH Lin, C Wang, RD Alvarez, ... Clinical Cancer Research 20 (3), 644-657, 2014 | 56 | 2014 |
| Development of DNA vaccine targeting E6 and E7 proteins of human papillomavirus 16 (HPV16) and HPV18 for immunotherapy in combination with recombinant vaccinia boost and PD-1 … S Peng, L Ferrall, S Gaillard, C Wang, WY Chi, CH Huang, RBS Roden, ... MBio 12 (1), 10.1128/mbio. 03224-20, 2021 | 51 | 2021 |
| Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data WC Chen, C Wang, H Li, N Lu, R Tiwari, Y Xu, LQ Yue Journal of Biopharmaceutical Statistics 30 (3), 508-520, 2020 | 47 | 2020 |
| Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies JW Wang, S Jagu, K Kwak, C Wang, S Peng, R Kirnbauer, RBS Roden Virology 449, 304-316, 2014 | 43 | 2014 |
| A note on MAR, identifying restrictions, model comparison, and sensitivity analysis in pattern mixture models with and without covariates for incomplete data C Wang, MJ Daniels Biometrics 67 (3), 810-818, 2011 | 43 | 2011 |
| Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects TH Kang, J Knoff, WH Yeh, B Yang, C Wang, YS Kim, TW Kim, TC Wu, ... PloS one 9 (7), e103562, 2014 | 38 | 2014 |
| Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies C Wang, N Lu, WC Chen, H Li, R Tiwari, Y Xu, LQ Yue Journal of biopharmaceutical statistics 30 (3), 495-507, 2020 | 36 | 2020 |
| Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine S Jagu, K Kwak, JT Schiller, DR Lowy, H Kleanthous, K Kalnin, C Wang, ... Journal of virology 87 (11), 6127-6136, 2013 | 35 | 2013 |
| Assessing the heterogeneity of treatment effects via potential outcomes of individual patients Z Zhang, C Wang, L Nie, G Soon Journal of the Royal Statistical Society Series C: Applied Statistics 62 (5 …, 2013 | 33 | 2013 |
Richard RodenProfessor, Department of Pathology, Johns Hopkins University在 jhmi.edu 的电子邮件经过验证
